Management of Stable Vitiligo—A Review of the Surgical Approach

At present, vitiligo is the most common depigmenting skin disorder, characterized by clearly demarcated discolored patches of various shapes and sizes. Depigmentation results from the initial dysfunction and subsequent destruction of melanin-producing cells, called melanocytes, which are located in the basal layer of the epidermis and in hair follicles. This review concludes that the extent of repigmentation, regardless of the treatment method, is greatest in stable localized vitiligo patients. The aim of this review is to provide an overview of the clinical evidence for which the vitiligo treatment method (cellular or tissue) is more effective. The treatment relies on multiple factors, ranging from patient skin predisposition for repigmentation to the experience of the facility performing the procedure. Vitiligo is a significant problem in modern society. Although it is a typically asymptomatic and not life-threatening disease, it may have significant psychological and emotional impacts. Standard treatment relies on pharmacotherapy and phototherapy; however, the treatment of patients with stable vitiligo varies. The stability of vitiligo more than often implies the exhaustion of the potential for skin self-repigmentation. Thus, the surgical methods that distribute normal melanocytes into the skin are crucial elements of these patients’ therapy. The most commonly used methods are described in the literature, with an indication of their recent progress and changes. In addition, information on the efficiency of the individual methods at specific locations is compiled in this study, and the prognostic factors indicating repigmentation are presented. Cellular methods are the best therapeutic option for large-sized lesions; although they are more exorbitant than tissue methods, they benefit from more rapid healing times and presenting fewer side effects. Dermoscopy is a valuable tool used to assess the further course of repigmentation, where it is of great value to evaluate the patient prior to and following an operation.

[1]  Yonghu Sun,et al.  Immunometabolism in the pathogenesis of vitiligo , 2022, Frontiers in Immunology.

[2]  M. Picardo,et al.  Regenerative Medicine-Based Treatment for Vitiligo: An Overview , 2022, Biomedicines.

[3]  S. Sood,et al.  Management of vitiligo with topical janus tyrosine kinase inhibitor therapy: An evidence-based review , 2022, JAAD International.

[4]  Yifei Feng,et al.  Advances in vitiligo: Update on therapeutic targets , 2022, Frontiers in Immunology.

[5]  M. McCrary,et al.  Utilization of Our Toolkit: A Systematic Review and Meta-analysis of Surgical Therapies in Vitiligo Treatment , 2022, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[6]  A. El-Ashmawy,et al.  Clinical and dermoscopic evaluation of follicular unit transplantation vs. Mini‐Punch grafting in the repigmentation of resistant and stable vitiligo: A comparative study , 2022, Journal of cosmetic dermatology.

[7]  H. Miot,et al.  Update on the pathogenesis of vitiligo , 2022, Anais brasileiros de dermatologia.

[8]  Richard L. Miller,et al.  A Literature Review Investigating the Use of Topical Janus Kinase Inhibitors for the Treatment of Vitiligo. , 2022, The Journal of clinical and aesthetic dermatology.

[9]  W. Placek,et al.  Surgical Treatment of Vitiligo , 2022, International journal of environmental research and public health.

[10]  Saman Mohammadi,et al.  Efficacy and safety of traditional and surgical treatment modalities in segmental vitiligo: A review article , 2022, Journal of cosmetic dermatology.

[11]  T. Kawakami Surgical procedures and innovative approaches for vitiligo regenerative treatment and melanocytorrhagy , 2022, The Journal of dermatology.

[12]  Yu-Huei Huang,et al.  A comparative study of suction blister epidermal grafting and automated blister epidermal micrograft in stable vitiligo , 2022, Scientific reports.

[13]  M. Ramam,et al.  Disease Stability in Segmental and Non-Segmental Vitiligo , 2021, Indian dermatology online journal.

[14]  Yogesh M Bhingradia,et al.  Pinhole technique for cobblestoning in patients post mini-punch grafting for stable vitiligo. , 2021, Indian Journal of Dermatology, Venereology and Leprology.

[15]  F. Lin,et al.  CXCL9 as a key biomarker of vitiligo activity and prediction of the success of cultured melanocyte transplantation , 2021, Scientific Reports.

[16]  B. Khaitan,et al.  Autoimmunity in vitiligo: Therapeutic implications and opportunities. , 2021, Autoimmunity reviews.

[17]  B. Kar,et al.  Use of disposable syringe for transfer of graft in Suction Blister Epidermal Grafting. , 2021, Journal of American Academy of Dermatology.

[18]  K. Vinay,et al.  Transplantation of non‐cultured epidermal cell suspension in a case of segmental vitiligo with post‐treatment scarring , 2021, Journal of cosmetic dermatology.

[19]  S. Dogra,et al.  Dermatoscopic assessment of treatment response in patients undergoing autologous non‐cultured epidermal cell suspension for the treatment of stable vitiligo: A prospective study , 2021, Dermatologic therapy.

[20]  T. Lotti,et al.  Vitiligo: What’s old, what’s new , 2021, Dermatology reports.

[21]  C. Farid,et al.  Transverse Needling After Autologous Mini-Punch Grafts Improves Repigmentation in Stable Non-Segmental Vitiligo , 2021, Clinical, cosmetic and investigational dermatology.

[22]  M. Hashme,et al.  British Association of Dermatologists guidelines for the management of people with vitiligo 2021 * , 2021, The British journal of dermatology.

[23]  N. Deshmukh,et al.  Follicular Unit Extraction [FUE] – One Procedure, Many Uses , 2021, Indian Dermatology Online Journal.

[24]  A. Bishnoi,et al.  Clinical aspects of vitiligo. , 2021, Pigment cell & melanoma research.

[25]  J. Bae,et al.  Surgical Interventions for Patients With Vitiligo: A Systematic Review and Meta-analysis. , 2021, JAMA dermatology.

[26]  Wei‐song Hong,et al.  A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte–keratinocyte transplantation , 2021, Aging.

[27]  A. Wolkerstorfer,et al.  Donor to recipient ratios in the surgical treatment of vitiligo and piebaldism: a systematic review , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

[28]  M. Soltan,et al.  Effect of platelet‐rich plasma on the outcome of mini‐punch grafting procedure in localized stable vitiligo: Clinical evaluation and relation to lesional basic fibroblast growth factor , 2021, Dermatologic therapy.

[29]  T. Kaur,et al.  Comparative Evaluation of Efficacy of Non-cultured Epidermal Cell Suspension and Epidermal Curettage in Stable Vitiligo , 2021, Journal of cutaneous and aesthetic surgery.

[30]  S. Mutalik,et al.  Innovative Technique for Securing Autologous Melanocyte-keratinocyte Cell Transplant (MKCT) Suspension in Stable Vitiligo , 2021, Journal of cutaneous and aesthetic surgery.

[31]  N. Aghdami,et al.  Hair Follicle as a Source of Pigment-Producing Cells for Treatment of Vitiligo: An Alternative to Epidermis? , 2020, Tissue Engineering and Regenerative Medicine.

[32]  S. Chand,et al.  A Prospective Observational Comparative Study of Novel Autologous Negative Pressure Epidermal Harvesting System (ANPEHS or EHS) and Suction Blister Grafting (SBG) in Treatment of Stable Vitiligo , 2020, Journal of Cutaneous and Aesthetic Surgery.

[33]  Vinod K. Sharma,et al.  Comparison of efficacy of noncultured hair follicle cell suspension and noncultured epidermal cell suspension in repigmentation of leukotrichia and skin patch in vitiligo: a randomized trial , 2020, International journal of dermatology.

[34]  Aditi Agrawal,et al.  A Comparative Study between Follicular Unit Transplantation and Autologous Non-cultured Non-trypsinized Epidermal Cells Grafting (Jodhpur Technique) in Stable Vitiligo , 2020, Journal of cutaneous and aesthetic surgery.

[35]  K. Vinay,et al.  A prospective study to assess the efficacy of various surgical modalities in treatment of stable vitiligo patches over resistant sites , 2020, International journal of dermatology.

[36]  Z. E. El Maadawi,et al.  Value of silicone gel in prevention of cobblestoning following punch minigrafting in vitiligo , 2020, The Journal of dermatological treatment.

[37]  M. Khorshied,et al.  Studying the effect of adding growth factors to the autologous melanocyte keratinocyte suspension in segmental vitiligo , 2020, Dermatologic therapy.

[38]  A. Fleischer,et al.  The enigma and challenges of vitiligo pathophysiology and treatment , 2020, Pigment cell & melanoma research.

[39]  L. Rashed,et al.  Sensitivity of serum S100B protein as a disease activity marker in Egyptian patients with vitiligo (case-control study) , 2020, Archives of physiology and biochemistry.

[40]  K. Ezzedine,et al.  Vitiligo: A Review , 2020, Dermatology.

[41]  A. Wolkerstorfer,et al.  Reliability and validity of the Vitiligo Signs of Activity Score (VSAS) , 2020, The British journal of dermatology.

[42]  D. Parsad,et al.  Effect of Different Methods of Trypsinization on Cell Viability and Clinical Outcome in Vitiligo Patients Undergoing Noncultured Epidermal Cellular Suspension. , 2020, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[43]  T. Anbar,et al.  Noncultured epidermal suspensions obtained from partial‐thickness epidermal cuts and suction blister roofs for vitiligo treatment: A prospective comparative study , 2020, Journal of cosmetic dermatology.

[44]  V. Sharma,et al.  A randomized pilot study to compare hair follicle cell suspensions prepared using trypsin alone versus trypsin in combination with collagenase type I for transplantation in vitiligo , 2020, Clinical and experimental dermatology.

[45]  J. Ocampo-Candiani,et al.  Stable segmental vitiligo treated with punch mini‐grafts and narrow band UVB phototherapy , 2020, The Australasian journal of dermatology.

[46]  T. Anbar,et al.  Factors affecting the outcome of the suction blisters using two different harvesting techniques in vitiligo patients , 2019, Journal of cosmetic dermatology.

[47]  K. Chanprapaph,et al.  Outcome of Repeated Use of Donor Site for Noncultured Epidermal Cellular Grafting in Stable Vitiligo: A Retrospective Study , 2019, BioMed research international.

[48]  Mingfu Zhao,et al.  A self-controlled comparative study of mini punch graft versus suction blister epidermal graft in the treatment of stable vitiligo , 2019, The Journal of dermatological treatment.

[49]  K. Ezzedine,et al.  Six‐year follow‐up of vitiligo patients successfully treated with autologous non‐cultured melanocyte–keratinocyte transplantation , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[50]  T. Hussein,et al.  Noncultured Extracted Hair Follicle Outer Root Sheath Cell Suspension versus Noncultured Epidermal Cell Suspension in the Treatment of Stable Vitiligo , 2019, Journal of cutaneous and aesthetic surgery.

[51]  R. Kaufmann,et al.  Suction blister epidermal graft (SBEG) – an easy way to apply this method , 2019, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[52]  Shuli Li,et al.  Perspectives of New Advances in the Pathogenesis of Vitiligo: From Oxidative Stress to Autoimmunity , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[53]  M. Abu El-Hamd,et al.  A comparative study between suction blistering graft, mini punch graft, and hair follicle transplant in treatment of patients with stable vitiligo , 2018, The Journal of dermatological treatment.

[54]  R. Mohammed,et al.  The effect of NB‐UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor‐to‐recipient ratios , 2018, Journal of cosmetic dermatology.

[55]  G. Chodorowska,et al.  Localized scleroderma (morphea). Diagnostic and therapeutic recommendations of the Polish Dermatological Society , 2019, Dermatology Review.

[56]  B. Antonisamy,et al.  Cross-Sectional Study of Dermatoscopic Findings in Relation to Activity in Vitiligo: BPLeFoSK Criteria for Stability , 2019, Journal of cutaneous and aesthetic surgery.

[57]  L. Rudnicka,et al.  Vitiligo. Diagnostic and therapeutic recommendations of the Polish Dermatological Society , 2019, Dermatology Review.

[58]  A. Arora,et al.  Laser Ablation of the Recipient Area With Platelet-Rich Plasma–Enriched Epidermal Suspension Transplant in Vitiligo Surgery: A Pilot Study , 2019, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[59]  T. Hirobe,et al.  Excellent color-matched repigmentation of human vitiligo can be obtained by mini-punch grafting using a machine in combination with ultraviolet therapy , 2018, Dermatologica Sinica.

[60]  M. Sokołowska-Wojdyło,et al.  Efficacy of suction blister epidermal grafting with concomitant phototherapy in vitiligo treatment , 2018, Postepy dermatologii i alergologii.

[61]  S. Rani,et al.  Combination of Follicular and Epidermal Cell Suspension as a Novel Surgical Approach in Difficult-to-Treat Vitiligo: A Randomized Clinical Trial , 2018, JAMA dermatology.

[62]  Vinod K. Sharma,et al.  Study of efficacy and safety of noncultured, extracted follicular outer root sheath cell suspension transplantation in the management of stable vitiligo , 2018, International journal of dermatology.

[63]  A. Lallas,et al.  Dermoscopy in vitiligo: diagnosis and beyond , 2018, International journal of dermatology.

[64]  B. Kar,et al.  Suction Blister Epidermal Grafting for Vitiligo Involving Angles of Lip: Experience of 112 Patients , 2018, Journal of cutaneous and aesthetic surgery.

[65]  Yen-Jen Wang,et al.  Wood's lamp for vitiligo disease stability and early recognition of initiative pigmentation after epidermal grafting , 2017, International wound journal.

[66]  G. Dellatorre,et al.  Optimizing suction blister epidermal graft technique in the surgical treatment of vitiligo* , 2017, Anais brasileiros de dermatologia.

[67]  T. Mohammad,et al.  Vitiligo Surgery: Shuffling Melanocytes. , 2017, The journal of investigative dermatology. Symposium proceedings.

[68]  S. de Schepper,et al.  Biomarkers of disease activity in vitiligo: A systematic review. , 2017, Autoimmunity reviews.

[69]  H. Kerr,et al.  Long‐term follow‐up of patients undergoing autologous noncultured melanocyte‐keratinocyte transplantation for vitiligo and other leukodermas , 2017, Journal of the American Academy of Dermatology.

[70]  N. van Geel,et al.  Vitiligo: An Update on Pathophysiology and Treatment Options , 2017, American Journal of Clinical Dermatology.

[71]  Y. Gauthier,et al.  Clinical markers of vitiligo activity , 2017, Journal of the American Academy of Dermatology.

[72]  Mariana Gontijo Ramos,et al.  Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo* , 2017, Anais brasileiros de dermatologia.

[73]  R. Spritz,et al.  Genetics of Vitiligo. , 2017, Dermatologic clinics.

[74]  T. Mohammad,et al.  Surgical Therapies for Vitiligo. , 2017, Dermatologic clinics.

[75]  A. Yadav,et al.  Clinicopathologic Analysis of Stable and Unstable Vitiligo: A Study of 66 Cases , 2016, The American Journal of dermatopathology.

[76]  A. Christiano,et al.  Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA). , 2016, Journal of the American Academy of Dermatology.

[77]  B. King,et al.  Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy. , 2015, JAMA dermatology.

[78]  K. Ezzedine,et al.  Vitiligo , 2015, The Lancet.

[79]  B. Daniel,et al.  Vitiligo treatment update , 2015, The Australasian journal of dermatology.

[80]  M. Picardo,et al.  Vitiligo: characterization of melanocytes in repigmented skin after punch grafting , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[81]  M. Abdallah,et al.  Assessment of tissue FoxP3+, CD4+ and CD8+ T‐cells in active and stable nonsegmental vitiligo , 2014, International journal of dermatology.

[82]  R. Czajkowski,et al.  Current aspects of vitiligo genetics , 2014, Postepy dermatologii i alergologii.

[83]  M. Picardo,et al.  Guidelines for the management of vitiligo: the European Dermatology Forum consensus , 2013, The British journal of dermatology.

[84]  K. Martin Silicon: the health benefits of a metalloid. , 2013, Metal ions in life sciences.

[85]  M. Picardo,et al.  Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference , 2012, Pigment cell & melanoma research.

[86]  N. Patel,et al.  Advanced Treatment Modalities for Vitiligo , 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[87]  Meaghan Daly,et al.  Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. , 2011, Journal of the American Academy of Dermatology.

[88]  Zhi-zhong Zheng,et al.  Suction Blister Epidermal Grafting Using a Modified Suction Method in the Treatment of Stable Vitiligo: A Retrospective Study , 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[89]  K. Wakamatsu,et al.  Melanocortin 1 receptor genotype: an important determinant of the damage response of melanocytes to ultraviolet radiation , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[90]  K. Lahiri EVOLUTION AND EVALUATION OF AUTOLOGOUS MINI PUNCH GRAFTING IN VITILIGO , 2009, Indian journal of dermatology.

[91]  W. Vanscheidt,et al.  Repigmentation by Outer-Root-Sheath-Derived Melanocytes: Proof of Concept in Vitiligo and Leucoderma , 2009, Dermatology.

[92]  P. Bahadoran,et al.  Classification of Surgical Therapies for Vitiligo , 2007 .

[93]  K. Lahiri,et al.  Repigmentation of vitiligo with punch grafting and narrow‐band UV‐B (311 nm) – a prospective study , 2006, International journal of dermatology.

[94]  M. Daly,et al.  Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.

[95]  L. Montes,et al.  Vitiligo , 2002, The Lancet.

[96]  J. Cloutier,et al.  Association of inhibitory tyrosine protein kinase p50csk with protein tyrosine phosphatase PEP in T cells and other hemopoietic cells. , 1996, The EMBO journal.

[97]  P. Majumder,et al.  Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. , 1994, American journal of human genetics.

[98]  J. Surlève‐Bazeille,et al.  Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions. , 1992, Journal of the American Academy of Dermatology.

[99]  R. Falabella Epidermal grafting. An original technique and its application in achromic and granulating areas. , 1971, Archives of dermatology.